Therapeutic Effects of the Sphingosine 1-Phosphate Receptor Modulator, Fingolimod (FTY720), on Experimental Autoimmune Encephalomyelitis

Documenti analoghi

• Targeting the Metabolism and Receptors of Sphingosine-1- Phosphate for the Treatment of Rheumatoid Arthritis
  di: Bourgoin, Sylvain G., et al.
  Pubblicazione: (2012)
• Experimental Autoimmune Encephalomyelitis
  di: Weissert, Robert
  Pubblicazione: (2012)
• The role of sphingosine-1-phosphate in the tumor microenvironment and its clinical implications
  di: Masato Nakajima, et al.
  Pubblicazione: (2017-04-01)
• Modelling of Autoimmune Encephalomyelitis in a Non-Human Primate
  di: Jagessar, S. Anwar, et al.
  Pubblicazione: (2011)
• Therapeutics Potential of Cronassial in Experimental Autoimmune Encephalomyelitis: Insights Into Glycosphingolipids and Humoral Immunity
  di: Gayane Ghazaryan, et al.
  Pubblicazione: (2025-01-01)